Collectively, the numbers of Th1, Th17, Treg, Tfh, and B cells and contents of IFN-γ, IL-17, IL-10, IL-21, and titer of IgG could be useful indicators for the treatment of MG. This evidence concerns the gene IFNG and myasthenia gravis.